207 related articles for article (PubMed ID: 23437196)
1. Roles and mechanism of miR-199a and miR-125b in tumor angiogenesis.
He J; Jing Y; Li W; Qian X; Xu Q; Li FS; Liu LZ; Jiang BH; Jiang Y
PLoS One; 2013; 8(2):e56647. PubMed ID: 23437196
[TBL] [Abstract][Full Text] [Related]
2. Influence of miR-199a on rats with non-small cell lung cancer via regulating the HIF-1α/VEGF signaling pathway.
Wang LM; Zhang LL; Wang LW; Zhu L; Ma XX
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10363-10369. PubMed ID: 31841190
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-199a-3p inhibits angiogenesis by targeting the VEGF/PI3K/AKT signalling pathway in an in vitro model of diabetic retinopathy.
Wang L; Liu WX; Huang XG
Exp Mol Pathol; 2020 Oct; 116():104488. PubMed ID: 32622012
[TBL] [Abstract][Full Text] [Related]
4. MiR-199a inhibits the angiogenic potential of endometrial stromal cells under hypoxia by targeting HIF-1α/VEGF pathway.
Dai L; Lou W; Zhu J; Zhou X; Di W
Int J Clin Exp Pathol; 2015; 8(5):4735-44. PubMed ID: 26191163
[TBL] [Abstract][Full Text] [Related]
5. Reactive oxygen species regulate ERBB2 and ERBB3 expression via miR-199a/125b and DNA methylation.
He J; Xu Q; Jing Y; Agani F; Qian X; Carpenter R; Li Q; Wang XR; Peiper SS; Lu Z; Liu LZ; Jiang BH
EMBO Rep; 2012 Dec; 13(12):1116-22. PubMed ID: 23146892
[TBL] [Abstract][Full Text] [Related]
6. Targeting of multiple myeloma-related angiogenesis by miR-199a-5p mimics: in vitro and in vivo anti-tumor activity.
Raimondi L; Amodio N; Di Martino MT; Altomare E; Leotta M; Caracciolo D; Gullà A; Neri A; Taverna S; D'Aquila P; Alessandro R; Giordano A; Tagliaferri P; Tassone P
Oncotarget; 2014 May; 5(10):3039-54. PubMed ID: 24839982
[TBL] [Abstract][Full Text] [Related]
7. CCL5 promotes vascular endothelial growth factor expression and induces angiogenesis by down-regulating miR-199a in human chondrosarcoma cells.
Liu GT; Huang YL; Tzeng HE; Tsai CH; Wang SW; Tang CH
Cancer Lett; 2015 Feb; 357(2):476-87. PubMed ID: 25444917
[TBL] [Abstract][Full Text] [Related]
8. miR-148a inhibits early relapsed colorectal cancers and the secretion of VEGF by indirectly targeting HIF-1α under non-hypoxia/hypoxia conditions.
Tsai HL; Miao ZF; Chen YT; Huang CW; Yeh YS; Yang IP; Wang JY
J Cell Mol Med; 2019 May; 23(5):3572-3582. PubMed ID: 30834693
[TBL] [Abstract][Full Text] [Related]
9. miR-199a Downregulation as a Driver of the NOX4/HIF-1α/VEGF-A Pathway in Thyroid and Orbital Adipose Tissues from Graves' Patients.
Craps J; Joris V; Baldeschi L; Daumerie C; Camboni A; Buemi A; Lengelé B; Behets C; Boschi A; Mourad M; Many MC; Dessy C
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008579
[TBL] [Abstract][Full Text] [Related]
10. MiR-21 induced angiogenesis through AKT and ERK activation and HIF-1α expression.
Liu LZ; Li C; Chen Q; Jing Y; Carpenter R; Jiang Y; Kung HF; Lai L; Jiang BH
PLoS One; 2011 Apr; 6(4):e19139. PubMed ID: 21544242
[TBL] [Abstract][Full Text] [Related]
11. Adrenomedullin promotes angiogenesis in epithelial ovarian cancer through upregulating hypoxia-inducible factor-1α and vascular endothelial growth factor.
Zhang Y; Xu Y; Ma J; Pang X; Dong M
Sci Rep; 2017 Jan; 7():40524. PubMed ID: 28091613
[TBL] [Abstract][Full Text] [Related]
12. miR-497 suppresses angiogenesis in breast carcinoma by targeting HIF-1α.
Wu Z; Cai X; Huang C; Xu J; Liu A
Oncol Rep; 2016 Mar; 35(3):1696-702. PubMed ID: 26718330
[TBL] [Abstract][Full Text] [Related]
13. MiRNA199a-3p suppresses tumor growth, migration, invasion and angiogenesis in hepatocellular carcinoma by targeting VEGFA, VEGFR1, VEGFR2, HGF and MMP2.
Ghosh A; Dasgupta D; Ghosh A; Roychoudhury S; Kumar D; Gorain M; Butti R; Datta S; Agarwal S; Gupta S; Krishna Dhali G; Chowdhury A; Schmittgen TD; Kundu GC; Banerjee S
Cell Death Dis; 2017 Mar; 8(3):e2706. PubMed ID: 28358369
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells.
Pakravan K; Babashah S; Sadeghizadeh M; Mowla SJ; Mossahebi-Mohammadi M; Ataei F; Dana N; Javan M
Cell Oncol (Dordr); 2017 Oct; 40(5):457-470. PubMed ID: 28741069
[TBL] [Abstract][Full Text] [Related]
15. Dynamin 2 along with microRNA-199a reciprocally regulate hypoxia-inducible factors and ovarian cancer metastasis.
Joshi HP; Subramanian IV; Schnettler EK; Ghosh G; Rupaimoole R; Evans C; Saluja M; Jing Y; Cristina I; Roy S; Zeng Y; Shah VH; Sood AK; Ramakrishnan S
Proc Natl Acad Sci U S A; 2014 Apr; 111(14):5331-6. PubMed ID: 24706848
[TBL] [Abstract][Full Text] [Related]
16. The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma.
Kinose Y; Sawada K; Nakamura K; Sawada I; Toda A; Nakatsuka E; Hashimoto K; Mabuchi S; Takahashi K; Kurachi H; Lengyel E; Kimura T
Oncotarget; 2015 May; 6(13):11342-56. PubMed ID: 25839163
[TBL] [Abstract][Full Text] [Related]
17. MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis.
Xu Q; Liu LZ; Qian X; Chen Q; Jiang Y; Li D; Lai L; Jiang BH
Nucleic Acids Res; 2012 Jan; 40(2):761-74. PubMed ID: 21917858
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs 125a and 125b inhibit ovarian cancer cells through post-transcriptional inactivation of EIF4EBP1.
Lee M; Kim EJ; Jeon MJ
Oncotarget; 2016 Feb; 7(8):8726-42. PubMed ID: 26646586
[TBL] [Abstract][Full Text] [Related]
19. The expression of miR-125b regulates angiogenesis during the recovery of heat-denatured HUVECs.
Zhou S; Zhang P; Liang P; Huang X
Burns; 2015 Jun; 41(4):803-11. PubMed ID: 25468475
[TBL] [Abstract][Full Text] [Related]
20. miR-199a-3p enhances cisplatin sensitivity of ovarian cancer cells by targeting ITGB8.
Cui Y; Wu F; Tian D; Wang T; Lu T; Huang X; Zhang P; Qin L
Oncol Rep; 2018 Apr; 39(4):1649-1657. PubMed ID: 29436681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
